Navigation Links
Remedy Informatics CEO, Gary Kennedy, to Speak at Molecular Med TRI-CON
Date:2/16/2012

SALT LAKE CITY, Feb. 16, 2012  /PRNewswire/ -- Remedy Informatics, the leading provider of integrated research management systems for Life Science and Translational research, announced that its Founder and CEO, Gary Kennedy, will participate as a speaker in the Integrated R&D Informatics and Knowledge Management Track on Tuesday, Feb. 21, and as an expert panelist on Wednesday, Feb. 22 at Molecular Med TRI-CON Feb. 19-23, 2012, in San Francisco, Calif. (Booth #604).

(Logo: http://photos.prnewswire.com/prnh/20120206/SF47874LOGO)

Mr. Kennedy's presentation on Tuesday, titled, "Aggregating & Harmonizing Disparate Data Sources: The Key to Pattern Recognition," will address the fundamental data problems faced by life science and translational researchers – integrating research systems and breaking down silos, generating complete and accurate data sets, and making data accessible with easy-to-use pattern recognition tools. He will also describe how modern ontology-based informatics systems hosted in the cloud can provide a competitive advantage via predictive informatics.

The plenary keynote panel on Wednesday, titled, "Emerging Technologies & Industry Perspectives," will offer conference attendees a look at "emerging and hot technologies in diagnostics, drug discovery and development, informatics, and oncology." A Q&A discussion will also provide attendees an opportunity to interact with panel members.

More information regarding Mr. Kennedy's talk or the expert panel discussion is available on the Molecular Med TRI-CON website, www.triconference.com.

Remedy will also demo Investigate™, the world's first integrated translational research management system at the conference. The product will be featured in the New Product Pavilion at Molecular Med TRI-CON.

"Investigate is designed to improve research efficiencies, facilitate pattern recognition and accelerate discoveries in translational research settings," said Hank Wu, Director of Translational Informatics and Investigate product manager for Remedy.

Investigate is a unique tool available to translational researchers because it integrates next-generation sequencing systems with patient and disease registries and biospecimen management. Researchers benefit from:

  • Aggregation of disparate data types from bench to bedside data sources with an intelligent ontology that harmonizes biospecimen, registry and outcomes data
  • 360 degrees perspective of phenotypic and genotypic data for subjects, patients, diseases
  • Configurability that keeps up with the pace of research, without waiting for software coding or database administration
  • Multi-site, cross disease research collaboration without the cost and complexity of infrastructure building and maintenance
  • A suite of reporting, analysis, and data visualization tools that enable drag-and-drop reporting by researchers, scientists, and clinicians without writing SQL

Investigate was recently selected by SAIC-Frederick, Inc., the operations contractor for the National Cancer Institute's Frederick, Md. campus, as the research informatics platform for ten high profile cancer research laboratories to integrate lab information management systems (LIMS), study design and tracking, patient registries, and data mining and visualization.

Remedy will demonstrate Investigate at BOOTH #604 at the Molecular Med TRI-CON 2012 conference in San Francisco, Calif. beginning Feb. 21 – Feb. 23.

About Remedy Informatics, Inc.

Remedy Informatics, Inc. is the leading provider of clinical registries, integrated research management software, and research informatics products that accelerate translational medicine discoveries from bench to bedside. Remedy offers a wide range of configurable "off the shelf" biomedical informatics products that are built on the powerful Mosaic™ Platform. Remedy's mission is to tangibly, measurably and permanently improve the effectiveness of Life Science and Translational Research in the United States and across the globe.  For more information visit: www.remedyinformatics.com.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Mike Cummens
https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=106822

Gary Kennedy
https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=106824

Hank Wu
https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=106850

Media Contacts
Kristofer Beldin, Remedy Informatics, (801) 870-9407 (cell), kris.beldin@remedyinformatics.com


'/>"/>
SOURCE Remedy Informatics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Phytomedics Inc. Announces Publication of the Phase 2b Clinical Trial Results of an Extract of the Chinese Herbal Remedy Tripterygium wilfordii Hook F in Rheumatoid Arthritis
2. Fresenius Medical Care, N.A. Has Selected VitalRemedyMDs VitalProteinRx(TM) As Its Bar of Choice for Protein Replacement in Dialysis Patients
3. Cold-EEZE® Cold Remedy Awarded Coveted Parent Tested Parent Approved (PTPA) Seal of Approval
4. Cold-EEZE® Cold Remedy Announces Winners in its "Share Your Cause Not Your Cold" Campaign
5. RemedyMD Announces Investigate Cell Therapy, a Revolutionary Research Management System for Blood and Marrow Transplant Centers
6. Perceptive Informatics Improves Clinical Trial Management With Enhanced TrialWorks(R) Solution
7. Perceptive Informatics Introduces Medical Imaging Methodology to Accelerate Development Decisions About Alzheimers Treatments
8. Perceptive Informatics Survey Results Reveal Top Barriers to Implementing Adaptive Trial Designs
9. BioInformatics, LLC New Report - Capitalizing on New Opportunities for Stem Cell Products, Now Available
10. Perceptive Informatics Enhances Investigator Application of New RECIST Version in Imaging-Based Oncology Trials
11. FUJIFILM Establishes Medical Informatics Organization
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2017)... Massachusetts , July 25, 2017 The med-tech ... rare nervous system diseases, has concluded a worldwide license agreement ... drug SOM0226 against transthyretin amyloidosis (ATTR). Before this licensing agreement ... a Phase 2 study conducted in Europe ... the United States ...
(Date:7/24/2017)... , July 24, 2017  Diplomat Pharmacy, Inc. (NYSE: ... release its second quarter 2017 operating results on Monday, ... call to follow at 5:00 p.m. ET. ... listen to a live broadcast of the conference call ... referencing participant code 51641230 approximately 15 minutes prior to ...
(Date:7/21/2017)... International plc (NASDAQ: ENDP ) today announced ... network, the Company will be ceasing operations and closing ... Alabama . The closure of the facilities is ... 18 months. The Huntsville location ... and these restructuring actions are intended to better match ...
Breaking Medicine Technology:
(Date:7/24/2017)... , ... July 24, 2017 ... ... Director,      (407) 916-7235, kklaproth(at)robinsmorton(dot)com , Robins & Morton, Perkins ... to celebrate the structural topping out of the new Destination Medical Building ...
(Date:7/24/2017)... , ... July 24, 2017 , ... SignatureCare Emergency ... will be awarded for the fall semester to a deserving student. Get your ... Spring 2017 scholarship was awarded to Mariana Castillo who is a nursing student at ...
(Date:7/24/2017)... ... July 24, 2017 , ... ... Abuse and Mental Health Services Administration’s (SAMHSA) State Targeted Response to the Opioid ... Health Care Services, will facilitate the development of a hub and spoke model ...
(Date:7/24/2017)... ... July 24, 2017 , ... ... effectively destroyed the construction site and threatened numerous homes and businesses nearby, causing ... article on NBCLosAngeles.com. Los Angeles Area consulting firm Fire Protection Group, Inc. ...
(Date:7/24/2017)... ... July 24, 2017 , ... The International Essential Tremor Foundation (IETF) will ... essential tremor (ET). The seminar will take place on Saturday, Aug. 26 at the ... The program will run from 9 a.m. to 12 p.m., with check-in beginning at ...
Breaking Medicine News(10 mins):